About Chambio
Chambio Co., Ltd. is an integrated life science company founded in 2007 by a group of highly skilled and experienced professionals and researchers. We are one of the leading companies in Taiwan's dietary supplement industry, specializing in supplying safe and effective functional ingredients, premixes and tailor-made finished products to many regions including Taiwan, China, Korea, Japan, Europe, Australia, Canada, ASEAN and etc.
We offer total solution services, ranging from providing raw ingredients, product concepts, formulations, technical supports to OEM/ODM for specialized and customized final products with high quality and competitive advantages.
Our main focus is on the management of proprietary raw ingredients and innovative formulas, we work with many internationally renowned companies from Europe, United States, Japan, South Korea, etc. and we distribute more than 30 world-class branded bioactive ingredients.
Our customers includes many famous pharmaceutical, nutraceutical, cosmeceutical, supplement, food, beverage and cosmetic manufacturers and retailers. We are also the contract manufacturer for several multinational companies.
We are fully committed to quality control, in order to build and foster our customers’ confidence. In addition to our ISO-9001 & ISO-22000 and HACCP certified quality control system, we also set up our own RD/QC laboratory and a professional team to make sure that our customers’ products are of the highest standard.
Further, to fortify our customers’ trust in us and our company’s business creditworthiness, we have engaged the services of Dun & Bradstreet to independently rate and verify to our company.
A name you can trust!
- Head Office (Taiwan): Chambio Co., Ltd.
- Branch (Taiwan): Chambio Technology Co., Ltd.
- Branch (Shanghai): Chambio Biotech Co., Ltd.
D-U-N-S® Number: 656268245, D&B Rating: 3A2
A member of IPA
Chambio's Laboratory
Our brand value is built on extensive scientific researches, sufficient safety data and reliable quality assurances.
We ensure efficacy and safety through clinical trials, scientific literatures, patents, safety data, third lab. test reports and more.
Mission & Vision
Quality, Safety, Efficacy and Service are the cornerstones of which Chambio’s corporate mission is built upon. We also believe that Honesty is the best policy. In order to achieve our corporate mission, we have been committed to investing much of our resources to upgrade our knowledges and capabilities. As such, we have generated mutual benefits with our customers by providing excellent products and technology-enriched solutions. We support our customers with sales and market expansion strategies, while also adding value to their products. Our ultimate goal is to provide products and services that exceeded customer's expectations.
Innovation Driven
Patent Application & Grant :
| Patent title | Granted | Pending | |
| Taiwan | 後生元提取物的製備方法以及由該方法所得到的產物及其用於抑制生物膜形成與促進腸道健康之用途。 A method for preparing postbiotic extract, and its products obtained therefrom for inhibiting biofilm formation and promoting intestinal health. | TW I733446 | |
| 後生元提取物用於預防和/或治療關節炎與關節退化的用途。 The use of postbiotic extract for the prevention and/or treatment of arthritis and joint degeneration. | TW I739424 | ||
| 後生元提取物用於促進皮膚再生與抗老化的用途。 The use of postbiotic extract for promoting skin regeneration and anti-aging. | TW I748448 | ||
| 具有核殼結構的益生菌顆粒。 Probiotic particles with nuclear-shell structure. | TW M602905U | ||
| 使用熱致死的乳酸菌菌株來治療和/或預防微粒物質-誘發的肺損傷。 The use of heat-killed Lactobacillus strains for treating and/or preventing particulate matter-induced lung injury. | TW I802009 | ||
| 使用一包含有植物乳桿菌 CB102 分離株與燕窩酸的組合來改善皮膚病況。 The use of a combination comprising a plant-derived Lactobacillus CB102 isolate and hyaluronic acid for improving skin conditions. | TW I808582 | ||
| 益生菌與後生元的組合在改善 SARS-CoV-2 感染相關的病況上的用途。 Method of using a combination of postbiotics and probiotics for prevention of severe acute respiratory syndrome coronavirus 2 infection-associated disorders. | 112120383 | ||
| 使用寡糖配方來生產乳酸菌脂壁酸的方法。 Method for producing lipoteichoic acid from lactic acid bacteria using an oligosaccharide formula | 113102293 | ||
| 具有穩定包覆活性成分能力之複合結構保健品。 A composite structural health supplement with the ability for stable encapsulation of active ingredients. | TW M655351 | ||
| 具有酵素活性物質之微粒結構保健品。 Health Supplement Containing Microparticle Structures with Enzymatic Activity. | TW M660619 | ||
| 植物乳桿菌 CB102 的後生元萃取物及其製備方法與降低血中尿酸用途。 The Preparation Method of Lactobacillus plantarum-derived Postbiotics CB-102 and Its Application in Reducing Blood Uric Acid Levels. | 113129230 | ||
| China | 後生元提取物的製法以及該方法得到的產物及其抑制生物膜形成與促進腸道健康的用途。 The method of preparing postbiotic extract, the product obtained by the method, and its use for inhibiting biofilm formation and promoting intestinal health. | CN 113925158B | |
| 後生元提取物用於預防和/或治療關節炎與關節退化的用途。 The use of postbiotic extract for the prevention and/or treatment of arthritis and joint degeneration. | CN 113925885B | ||
| 後生元提取物用於促進皮膚再生與抗老化的用途。 The use of postbiotic extract for promoting skin regeneration and anti-aging. | CN 113925884B | ||
| 具有核殼結構的益生菌顆粒及益生菌軟膠囊。 Probiotic particles with nuclear-shell structure and probiotic soft capsules. | CN 213549547U | ||
| 熱致死的乳酸菌菌株作為製備治療和/或預防微粒物質-誘發的肺損傷的醫藥品的用途。 The use of heat-killed Lactobacillus strains as a pharmaceutical preparation for the treatment and/or prevention of particulate matter-induced lung injury. | 202111291686.0 | ||
| 包含植物乳桿菌 CB102 與燕窩酸的組合在製備用來改善皮膚病況的組合物中的用途。 The use of a combination comprising a plant-derived Lactobacillus CB102 isolate and hyaluronic acid in the preparation of a composition for improving skin conditions. | 202211396626.X | ||
| 益生菌與後生元的組合在改善 SARS-CoV-2 感染相關的病況上的用途。 Method of using a combination of postbiotics and probiotics for prevention of severe acute respiratory syndrome coronavirus 2 infection-associated disorders. | 202310870474.0 | ||
| 植物乳桿菌 CB102 的後生元萃取物及其製備方法與降低血中尿酸用途。 The Preparation Method of Lactobacillus plantarum-derived Postbiotics CB-102 and Its Application in Reducing Blood Uric Acid Levels. | 202411226243.7 | ||
| USA | POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF. | US 11541085 B2 | |
| METHOD FOR ALLEVIATING ARTHRITIS WITH POSTBIOTIC EXTRACT. | US 11517596 B2 | ||
| METHOD FOR IMPROVING SKIN CONDITION WITH POSTBIOTIC EXTRACT. | US 11517597 B2 | ||
| POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF. "splitting case" (inhibiting biofilm formation) | US 11,931,388 B2 | ||
| POSTBIOTIC EXTRACT AND PREPARATION PROCESS AND USE THEREOF. "Splitting case" (promoting intestinal health) | US 11,925,668 B2 | ||
| METHOD FOR PREVENTING OR ALLEVIATING PARTICULATE MATTER-INDUCED LUNG INJURY. | US 12,090,182B2 | ||
| METHOD OF USING A COMBINATION OF POSTBIOTICS AND PROBIOTICS FOR PREVENTION OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 INFECTION-ASSOCIATED DISORDERS. | 18/499450 |
Papers：
| Year | Papers title | Journal/Exhibition name |
| 2023 | 後生元協同益生菌減輕由 PM2.5 引起的肺損傷及過敏。 Synergistic effect of probiotic and postbiotic on attenuation of PM2.5-induced lung damage and allergic response. | J Food Sci. 2023;88(1):513-522. doi:10.1111/1750-3841.16398 |
| 葉黃素、玉米黃素、綠薄荷萃取物降低網膜及角膜細胞氧化壓力具有加成效果。 The synergistic effects of lutein, zeaxanthin, and spearmint extract on the antioxidant activity in APRE-19 and HCE-T cells. | FAOPS Congress | |
| 久司酵素增強版透過纖維與體內油脂結合與促進排出來改善腸道健康。 BraziZyme® PLUS improves gastrointestinal health through its fiber-mediated binding and excretion of intracellular lipids. | 2023 台灣乳酸菌協會研討會。 2023 Taiwan Association for Lactic Acid Bacteria Conference. | |
| 2024 | 黑豆種皮萃取物及其複方具有保護角膜細胞之效果 Protective Effect of Black Bean Hull Extract and Its Formula on Human Corneal Epithelial Cells. | 2024台灣保健食品學會年會暨國際學術研討會 2024 Taiwan Health Food Society Annual Conference and International Academic Symposium |
| ProbioGABA® 倍乘配方對於睡眠品質與情緒穩定之改善效果 ProbioGABA®, the Synscience Inside Formula, improves Sleep Quality and Emotional Well-being. | 2024台灣營養學會年會暨學術研討會 2024 Nutrition Society of Taiwan Annual Conference and Academic Symposium |
Awards
| Year | Name | Award | Area |
| 2023 | 2023 營養智造-微生態先鋒獎_後生元乳酸菌三次方增肌複方。 2022 New Nutrition Business-Microecology Pioneer Award-Postbiotics Tri-Cubic Muscle Building Complex with Probiotic. | 新營養大會暨營養盒頒獎。 New Nutrition Business-Nutrition Box Award. | China |
| 益生聯®、益生捷® 和益生妍® 新系統用於抑制壞菌、促進腸道健康、預防和治療關節炎以及促進皮膚再生與抗老化。 A new system of Probiogenics®, ProbioFlex® and ProbioHya® inhibits harmful bacteria, improves gut health, prevents and treats arthritis, promotes skin regeneration and anti-aging. | 日本東京天才發明獎。 World Genius Convention & Education Expo - Gold Award. | Japan | |
| 瑞士日內瓦發明獎_特別獎。 Geneva International Exhibition of Inventions - Special Award. | Switzerland | ||
| 瑞士日內瓦發明金獎。 Geneva International Exhibition of Inventions - Gold Award. | Switzerland | ||
| 一種專利微活化的 / probioAid® / PROBIOPTIMA® LM-1004 後生元 ( 類生元® ) 技術。 A patented technology for micro-activating probioAid® / PROBIOPTIMA® LM1004 postbiotic. | iSEE 創新技術 TOP50 榜。 iSEE Award TOP50. | China | |
| 一種生產活性後生元 L-137 ( 類生元® ) 的熱封存技術。 A heat-treated technology for manufacturing bioavailable L-137 postbiotics. | iSEE 創新技術 TOP50 榜。 iSEE Award TOP50. | China | |
| 專利微活化後生元 probioAid® / PROBIOPTIMA® LM-1004 ( 類生元® )。 A patented technology for micro-activating probioAid® / PROBIOPTIMA® LM1004 postbiotic. | 天然新勢力_源創配料獎。 Natural New Force Awards. | China | |
| 2022 | PROBIOPTIMA® / probioAid® LM-1004 | 日本天才發明金獎_體重管理。 World Genius Convention & Education Expo - Gold Award in Weight Management. | Japan |
| 營養智造-解決方案開拓者獎。 2022 New Nutrition Business-Solution Pioneer Award. | 新營養大會暨營養盒頒獎。 New Nutrition Business-Nutrition Box Award. | China | |
| 2021 | 營養智造-新植物力量獎。 2021 New Nutrition Business-New Plant Power Award. | 新營養大會暨營養盒頒獎。 New Nutrition Business-Nutrition Box Award. | China |
| 2020 | 營養智造-應用之星獎。 2020 New Plant Power Award-Application Star Award. | 新營養大會暨營養盒頒獎。 New Nutrition Business-Nutrition Box Award. | China |
